http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1495665-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16890954fa97fa1ea88523e23b283152 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60 |
| filingDate | 1975-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1495665-A |
| titleOfInvention | Pyrimidines |
| abstract | 1495665 Pyrimidine compounds PRODUITS CHIMIQUES UGINE KUHLMANN 28 Jan 1975 [29 Jan 1974] 3579/75 Heading C2C The invention comprises compounds of formula and their salts with pharmaceutically acceptable acids, wherein R 1 and R 2 are each alkyl, benzyl or (possibly substituted) Ph, or NR 1 R 2 forms a heterocyclic ring; X is dialkylaminoalkyl or R 3 ; Y is Cl, alkoxy, dialkylaminoalkoxy or OR 4 ; and R 3 , R 4 are each a saturated N-heterocyclic ring. These compounds are prepared by reacting the corresponding 4,6-dichloro- or 4-Cl-6-XO-pyrimidine with the appropriate alcohol. Therapeutic compositions which may be administered orally, parenterally or rectally comprise compounds of the above formula; they have hypoglycaemic, hypolipaemic, hypocholesteraemic, hypophospholipaemic, spasmolytic, coronarydilatory and analgesic activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812159-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8933083-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007175-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838525-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-014156-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894787-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-748991-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546429-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006076243-A1 |
| priorityDate | 1974-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834 |
Total number of triples: 24.